Skip to main content

Nina Kjellson

Equibles does not estimate personal net worth.

Get an email with a short summary when Eloxx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get ELOX alerts

About Nina Kjellson

Nina Kjellson is recorded as Board Member at Eloxx Pharmaceuticals, Inc. (ELOX) since May 27, 2026. Eloxx Pharmaceuticals, Inc. reported in an 8-K filed June 1, 2026 that Nina Kjellson was appointed director, effective May 27, 2026. Eloxx Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eloxx Pharmaceuticals, Inc. includes Sumit Aggarwal (CEO and Board Member), Daniel Geffken (CFO and Chief Accounting Officer), Gary D. Rakers (CFO) and 7 others.

“On May 27, 2026, the Board of Directors (the "Board") of Eloxx Pharmaceuticals, Inc. (the "Company") appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board, and reduced the size of the Board from six to five directors.”
Eloxx Pharmaceuticals, Inc. Form 8-K, filed June 1, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Eloxx Pharmaceuticals, Inc.

Recent activity